Resale offerings end at BioLife Solutions (BLFS), after prior registration of up to 927,165 shares.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
BioLife Solutions, Inc. (BLFS) has terminated its resale stock offerings and deregistered all unsold securities that were part of a previous registration statement for up to 927,165 shares of common stock. This action follows a two-step merger completed on October 6, 2026, where BioLife Solutions became BioLife Solutions, LLC, a wholly owned subsidiary of Repligen Corporation. The termination aligns with undertakings to remove unsold securities after the offering's conclusion.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.